Research study Program year 2023 Source: CMS Open Payments

Rise H&H Hvs3

Research payments

$177,920

2 payments

Through program year 2023, $177,920 in research payments was reported against Rise H&H Hvs3, across 2 payments.

Paid by (largest first): Davol Inc.; C. R. Bard, Inc. & Subsidiaries
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$82,703	1
2022	Research	$95,218	1

Breakdown

Who paid Research payments · program years 2022–2023

Davol Inc. $95,218 1 payment
C. R. Bard, Inc. & Subsidiaries $82,703 1 payment

Who received the money Research payments · program years 2022–2023

TKL Research Inc. Organisation paid for research $95,218 1 payment
Tkl Research INC Organisation paid for research $82,703 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Jesson Yeh Teaneck, NJ Named on 2 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.